tailieunhanh - Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition

The hypoxia-activated prodrug TH-302 is reduced at its nitroimidazole group and selectively under hypoxic conditions releases the DNA cross-linker bromo-isophosphoramide mustard (Br-IPM). Here, we have explored the effect of Chk1 inhibition on TH-302-mediated pharmacological activities. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN